Expression of 2 variant forms of fibroblast growth factor receptor 1 in human breast
Autor: | Matthew Law, C. Mortimer, C. L. Johnston, R. C. Coombes, D Sinnett, G S Bansal, C Yiangou, Y. A. Luqmani |
---|---|
Rok vydání: | 1995 |
Předmět: |
Adult
Cancer Research Cell type medicine.medical_specialty medicine.medical_treatment Molecular Sequence Data Gene Expression Biology Fibroblast growth factor Paracrine signalling Internal medicine medicine Humans Breast RNA Messenger Receptor Autocrine signalling Aged DNA Primers Base Sequence Fibroblast growth factor receptor 1 Growth factor Middle Aged Receptors Fibroblast Growth Factor Molecular biology Gene Expression Regulation Neoplastic Alternative Splicing Endocrinology Oncology Fibroblast growth factor receptor Lymphatic Metastasis Female |
Zdroj: | International Journal of Cancer. 64:274-279 |
ISSN: | 1097-0215 0020-7136 |
Popis: | The expression of variant mRNAs encoding isoforms of fibroblast growth factor receptor (FGFR)1 with either 2 or 3 Ig-like loops in the extracellular domain was investigated in human breast tissues and cell lines using a polymerase chain reaction amplification method. Almost all tissues contained both forms of FGFR1, but cancers (n = 137) had a significantly lower proportion of the transcript that encoded the full 3-loop form compared with non-malignant biopsies (n = 34). This was confirmed using microdissected populations of normal and cancerous cells from frozen tissue sections. A high ratio of the 2- to 3-loop form was found to be predictive of reduced relapse-free survival. In both groups, however, the predominant form of FGFR1 was that encoding the 2-loop receptor. Cell lines derived from a variety of tissues, including breast, also co-expressed both variants of FGFR1, suggesting their presence within the same cell type. Again, there was a similar preponderance of the shorter isoform. Our results were confirmed at the protein level, where out of 5 cancers analysed 4 expressed more of the 2-loop form than the 3-loop form. Our findings suggest that cells may normally simultaneously express several splice variants of FGFR1, and aberrant expression or a change in their relative amounts (i.e., in malignancy) could contribute to modified responses to either autocrine or paracrine factors. |
Databáze: | OpenAIRE |
Externí odkaz: |